Craig Druehl > Dechert LLP > New York, United States > Lawyer Profile
Dechert LLP Offices
Dechert LLP
Three Bryant Park, 1095 Avenue of the Americas
NEW YORK, NY 10036-6797
NEW YORK
United States
Three Bryant Park, 1095 Avenue of the Americas
NEW YORK, NY 10036-6797
NEW YORK
United States
- Firm Profile
- Go to...
Craig Druehl
+1 212 698 3601 craig.druehl@dechert.com
Work Department
Financial Restructuring
Position
Partner
Career
Craig P. Druehl’s practice focuses on representing ad hoc groups and official committees of creditors, as well as distressed investors, lenders and other creditors in out-of-court restructurings and Chapter 11 and 15 cases. He also has substantial experience representing acquirers of assets in Chapter 11 cases, companies in out-of-court restructurings and Chapter 11 cases and parties to bankruptcy litigation.
Education
- Boston University School of Law, J.D., 1998, cum laude, Edward F. Hennessey Distinguished Scholar, Case & Note Editor of the American Journal of Law & Medicine
Judicial Intern, Honorable James F. Queenan of U.S. Bankruptcy Court for the District of Massachusetts - Middlebury College, B.A., 1994, cum laude
Top Tier Firm Rankings
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Environment > Environment: transactional
- Antitrust > Civil litigation/class actions: defense
- Investment fund formation and management > Mutual/registered/exchange-traded funds
- Dispute resolution > Product liability, mass tort and class action - defense: pharmaceuticals and medical devices
- Real estate > Real estate finance
- Finance > Structured finance: securitization
Firm Rankings
- Media, technology and telecoms > Cyber law (including data privacy and data protection)
- Dispute resolution > Product liability, mass tort and class action - defense: toxic tort
- Dispute resolution > Securities litigation: defense
- Antitrust > Civil litigation/class actions: defense
- Dispute resolution > E-discovery
- Finance > Fintech
- Dispute resolution > General commercial disputes
- Dispute resolution > International litigation
- Healthcare > Life sciences
- Dispute resolution > M&A litigation: defense
- Antitrust > Merger control
- Dispute resolution > Product liability, mass tort and class action - defense: consumer products (including tobacco)
- Finance > Restructuring (including bankruptcy): corporate
- Tax > US taxes: non-contentious
- Finance > Capital markets: debt offerings
- Finance > Capital markets: equity offerings
- Finance > Capital markets: global offerings
- International trade > Customs, export controls and economic sanctions
- Dispute resolution > International arbitration
- Intellectual property > Patents: prosecution (including re-examination and post-grant proceedings)
- M&A/corporate and commercial > Private equity buyouts: large deals ($500m+)
- Investment fund formation and management > Private equity funds (including venture capital)
- Labor and employment > Employee benefits, executive compensation and retirement plans: transactional
- Dispute resolution > Leading trial lawyers
- M&A/corporate and commercial > M&A: large deals ($1bn+)
- Intellectual property > Patents: litigation (full coverage)
- Finance > Capital markets: high-yield debt offerings
- Finance > Commercial lending
- Dispute resolution > Corporate investigations and white-collar criminal defense
- Investment fund formation and management > Alternative/hedge funds
- Dispute resolution > Financial services litigation
- Dispute resolution > Appellate: courts of appeals / Appellate: supreme courts (states and federal)